Cascadian Therapeutics Inc (CASC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2017 | 12-2016 | 12-2015 | 12-2014 | 12-2013 | |
| Operating Expenses | 58,089 | 64,835 | 32,789 | 50,835 | 41,223 |
| Operating Income | -58,089 | -64,835 | -32,789 | -50,835 | -41,223 |
| Other Income | 1,155 | 222 | 208 | 872 | 2,464 |
| Pre-tax Income | -56,934 | -64,613 | -32,581 | -49,963 | -38,759 |
| Income Tax | N/A | -6,908 | N/A | N/A | N/A |
| Net Income Continuous | -56,934 | -57,705 | -32,581 | -49,963 | -38,759 |
| Net Income | $-56,934 | $-57,705 | $-32,581 | $-49,963 | $-38,759 |
| EPS Basic Total Ops | -1.21 | -3.13 | -2.02 | -3.86 | -3.72 |
| EPS Basic Continuous Ops | -1.19 | -3.00 | -2.02 | -3.86 | -3.73 |
| EPS Diluted Total Ops | -1.21 | -3.13 | -2.02 | -3.86 | -3.72 |
| EPS Diluted Continuous Ops | -1.19 | -3.00 | -2.02 | -3.86 | -3.73 |
| EPS Diluted Before Non-Recurring Items | N/A | -2.11 | -2.04 | -1.98 | -3.96 |
| EBITDA(a) | $-57,139 | $-63,955 | $-31,871 | $-49,790 | $-40,083 |